MEDSUPPLY INTERNATIONAL UK LTD

Company Registration Number:
00498721 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2023

Period of accounts

Start date: 01 July 2022

End date: 31 December 2023

MEDSUPPLY INTERNATIONAL UK LTD

Contents of the Financial Statements

for the Period Ended 31 December 2023

Balance sheet
Notes

MEDSUPPLY INTERNATIONAL UK LTD

Balance sheet

As at 31 December 2023


Notes

18 months to 31 December 2023

2022


£

£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets:   0 0
Tangible assets:   0 0
Investments:   0 0
Total fixed assets: 0 0
Current assets
Stocks: 0 0
Debtors:   1,014 4,373,896
Cash at bank and in hand: 3,010 224,311
Investments:   0 1,428,048
Total current assets: 4,024 6,026,255
Creditors: amounts falling due within one year:   (3,294) (2,313,602)
Net current assets (liabilities): 730 3,712,653
Total assets less current liabilities: 730 3,712,653
Creditors: amounts falling due after more than one year:   0 0
Provision for liabilities: 0 0
Total net assets (liabilities): 730 3,712,653
Capital and reserves
Called up share capital: 730 730
Share premium account: 0 0
Revaluation reserve: 00
Other reserves: 0 0
Profit and loss account: 0 3,711,923
Shareholders funds: 730 3,712,653

The notes form part of these financial statements

MEDSUPPLY INTERNATIONAL UK LTD

Balance sheet statements

For the year ending 31 December 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 25 September 2024
and signed on behalf of the board by:

Name: Sune Svenningsen
Status: Director

The notes form part of these financial statements

MEDSUPPLY INTERNATIONAL UK LTD

Notes to the Financial Statements

for the Period Ended 31 December 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Other accounting policies

Related party transactions: The Company has taken advantage of the exemption under paragraph 8(k) of FRS 101 not to disclose transactions with fellow wholly owned subsidiaries.

MEDSUPPLY INTERNATIONAL UK LTD

Notes to the Financial Statements

for the Period Ended 31 December 2023

2. Employees

18 months to 31 December 2023 2022
Average number of employees during the period 0 36

MEDSUPPLY INTERNATIONAL UK LTD

Notes to the Financial Statements

for the Period Ended 31 December 2023

3. Related party transactions

Name of the related party: Medsupply International Holdings Pte Ltd
Relationship:
Parent company
Description of the Transaction: Dividend Declaration
£
Balance at 01 July 2022 2,031,794
Balance at 31 December 2023 284

Related party transactions: The Company has taken advantage of the exemption under paragraph 8(k) of FRS 101 not to disclose transactions with fellow wholly owned subsidiaries.